Email Connie at firstname.lastname@example.org for extra income that entails helping others get a final expense plan matching their needs. Covid proof income generation. There are leads and script and a team to help your business be your own agency owner. Not MLM.
Text Connie 408-854-1883. Must be in the USA. Have a car, computer and cell phone and a good communicator and listener.
Current Life and Health Insurance agents are welcome, up to 140% commission.
Contact Connie Dello Buono 408-854-1883 email@example.com if you wanted to be a med sales rep to show this test tool to US doctors. Doctors can use this genetic tests to personalize drugs based on each person genetic makeup. Now approved by insurance companies.
Pharmacogenetic test for patient safety, added value and income stream for doctors and to personalize medications
Pharmacogenetic testing (PGT) detects single nucleotide polymorphism of nine cytochrome P450 enzymes in the liver: CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, Factor II, Factor V, MTHFR, VKROC1.
By identifying the genotypes of these enzymes we can predict an individual’s ability to metabolize about 95% of all medications. The phenotypes are assigned based on the patients’ metabolizing ability as poor, intermediate, intermediate-extensive, extensive, and ultra-rapid metabolizers. Armed with the genetic information, physicians can provide personalized care by delivering the right medication at the right dosage to the right patient. In addition, PGT can help reduce adverse drug reactions, avoid drug interactions, prevent overdose and death, and save precious time and medical costs. Our lab’s PGT utilizes the state of the art Luminex 200 platform, FDA approved xTAG technologies, as well as laboratory-developed methods. The test is a simple non-invasive, buccal cell-based cheek swab. The PGT has a short turn-around time and easy to read lab reports.
Seniors, cancer, regimen of medications, sensitive,wants less drug reactions
Individuals who may benefit from PGT include patients with abnormally high or low metabolite to substrate ratios in urine drug screening, patients with multiple organ system issues or on multiple medications, patients who suffer from debilitating adverse drug reactions, and patients who have gone through sequential ineffective drug trials. PGT is proven a useful tool in chronic pain management where the use of narcotics and other medication is likely.
Hospitalization,death and other adverse drug reactions
According to the FDA, adverse drug reactions cause over 2 million hospitalizations per year and 106,000 annual deaths, while contributing $136 billion dollars to annual health care costs in our country. These are terrible statistics but the worst part is they are largely avoidable. The best part is that the technology is now available to every physician to ensure patient safety and the best possible treatment plan.